Kotyark Industries Limited has received a ₹173.45 crore biodiesel allocation under a joint tender involving Indian Oil Corporation (IOCL), Bharat Petroleum Corporation Limited (BPCL) and Hindustan Petroleum Corporation Limited (HPCL), adding a sizeable confirmed allocation to the company’s public-sector oil marketing company (OMC) business.
The company received an Award of Contract communication through the IOCL e-procurement portal on 10 August 2026 for Tender ID 2026_MKTHO_190226_1. The tender, issued pursuant to a joint Expression of Interest (EOI) by the three OMCs, carries an overall contract value of ₹1,397.72 crore, of which Kotyark’s allocation is ₹173.45 crore.
The company said the biodiesel supply is to be undertaken in Gujarat in accordance with the tender documents and the respective allocation and purchase-order terms.
The latest disclosure needs to be read alongside Kotyark Industries’ earlier August announcement. On 5 August, the company reported receiving LOIs from BPCL and HPCL covering a combined 1,662 kilolitres (KL) of biodiesel with an aggregate deliverable value of approximately ₹15.41 crore.
BPCL’s LOI covered 1,287 KL valued at approximately ₹11.93 crore, while HPCL’s covered 375 KL worth approximately ₹3.48 crore. Both allocations related to the June-August 2026 supply cycle in Gujarat.
The subsequent ₹173.45 crore Award of Contract expressly includes those earlier allocations. Consequently, the company’s disclosed OMC allocation should be viewed as ₹173.45 crore in total, rather than ₹188.86 crore obtained by adding the LOIs again.
OMC Tender Provides Visibility but Execution Remains Key
The order was awarded against a tender in which IOCL, BPCL and HPCL collectively sought biodiesel supplies. Kotyark’s ₹173.45 crore allocation represents about 12.4% of the ₹1,397.72 crore overall contract value.
The company stated that the supply is to be executed over a 92-day period from the date of the Award of Contract, with Gujarat identified as the supply location. The tender documentation also identifies the supply cycle as June to August 2026.
Because the award was received on 10 August while the tender supply period covered June-August, the precise timing of physical deliveries and revenue recognition should be assessed against the individual OMC indents, purchase orders and supply documentation rather than assuming that the entire allocation converts to revenue immediately.
Biodiesel Orders Follow Earlier OMC Engagement
The ₹173.45 crore allocation follows Kotyark’s participation in the OMCs’ joint EOI process.
The earlier BPCL and HPCL LOIs were issued directly by the OMCs without a separate allotment sheet, according to the company’s regulatory disclosure. Kotyark said this process was similar to tender cycles conducted in December 2025 and April 2025 and was intended to facilitate communication of allocations and subsequent purchase orders.
The latest contract therefore represents an expansion of an existing commercial relationship with India’s major fuel retailers rather than a completely new customer channel.
FY26 Revenue Reached ₹314.90 Crore
Kotyark Industries reported FY26 revenue of approximately ₹314.90 crore, according to financial data cited in the order coverage. That means the ₹173.45 crore allocation is equivalent to roughly 55% of FY26 revenue.
However, an order value should not be equated directly with incremental revenue or profit. Actual revenue recognition will depend on the quantities ultimately supplied, contractual pricing, delivery schedules and accounting treatment.
Quarterly performance has also been uneven. The company reported Q4FY26 revenue of ₹63.70 crore and net profit of ₹9.40 crore, with an operating profit margin of 30.07%. Q3FY26 revenue was higher at ₹103.90 crore, but net profit was ₹3.20 crore and operating margin was 9.52%. In Q4FY25, revenue stood at ₹20.20 crore and net profit at ₹1.50 crore.
The figures indicate that quarterly revenue and margins have varied significantly, making execution of the new allocation more important than the headline order value alone.
Cash Conversion Is an Important Execution Indicator
The company’s FY26 operating cash flow was reported at negative ₹3.90 crore, compared with positive operating cash flow of ₹30.90 crore in FY25.
For a biodiesel producer supplying large OMCs, working-capital requirements can become an important consideration when volumes increase. The key indicators to monitor will therefore include receivables, inventory requirements, payment cycles and the conversion of reported sales into operating cash.
The company also reported a current ratio of 3.22x and a total liabilities-to-equity ratio of 0.43x in the financial data accompanying the order disclosure.
Promoter Holding Falls in June 2026 Quarter
Kotyark’s promoter shareholding also changed materially during the June 2026 quarter.
Data compiled from exchange filings show promoter ownership falling from 63.84% in March 2026 to 57.34% in June 2026, a reduction of 6.50 percentage points. Public and other shareholder holdings increased correspondingly.
The change in ownership is a separate development from the biodiesel contract and does not, by itself, establish the reason for the reduction. Investors tracking the company would need to examine the underlying share transactions and subsequent disclosures to determine whether further changes occur.
What the ₹173.45 Crore Allocation Means for Kotyark
The contract gives Kotyark a significant allocation under a tender involving three of India’s largest public-sector fuel marketing companies. Relative to the company’s FY26 revenue base, the allocation is substantial, but its ultimate financial impact will depend on actual execution.
The most relevant near-term indicators are therefore physical biodiesel deliveries, the timing of purchase orders and indents, revenue recognised against the allocation, gross and operating margins on those supplies, and the associated working-capital cycle.
The earlier ₹15.41 crore BPCL and HPCL LOIs should also no longer be treated as an additional ₹15.41 crore on top of the ₹173.45 crore award because the company has explicitly stated that those earlier allocations are included in the latest figure.
Bioenergy Business Analysis
Kotyark’s latest OMC allocation is significant primarily because it combines a sizeable near-term biodiesel supply commitment with commercial access to IOCL, BPCL and HPCL. The ₹173.45 crore allocation is equivalent to more than half of the company’s FY26 revenue, giving execution a potentially material bearing on reported financial performance.
The more important question, however, is how much of the allocation translates into delivered volume, recognised revenue and operating cash flow. The company’s FY26 negative operating cash flow and pronounced quarter-to-quarter variation in revenue and margins make cash conversion and execution quality important metrics alongside the headline order value.
